Mobiamedical
4 known investors
Find your way into Mobiamedical
Sign up to see every warm intro you have to Mobiamedical
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Mobiamedical team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Mobia Medical (formerly MicroTransponder) develops Vivistim Paired VNS Therapy, an FDA-approved vagus nerve stimulation treatment for chronic ischemic stroke survivors with moderate to severe upper extremity impairment. It serves stroke patients and the clinicians who treat them in the medical device industry.
Founders & leadership
Investors · 4
How we know: Green Park & Golf Ventures's portfolio page · Not right? Tell us
How we know: Longitude Capital's portfolio page · Not right? Tell us
How we know: OUP (Osage University Partners)'s portfolio page · a partner's Signal profile · Not right? Tell us
How we know: US Venture Partners's portfolio page · a partner's Signal profile · Not right? Tell us
Frequently asked questions
- What does Mobiamedical do?
- Mobia Medical (formerly MicroTransponder) develops Vivistim Paired VNS Therapy, an FDA-approved vagus nerve stimulation treatment for chronic ischemic stroke survivors with moderate to severe upper extremity impairment. It serves stroke patients and the clinicians who treat them in the medical device industry.
- Who founded Mobiamedical?
- Mobiamedical was founded by Jordan Curnes.
- Who are Mobiamedical's investors?
- Mobiamedical's investors include Green Park & Golf Ventures, Longitude Capital, OUP (Osage University Partners), US Venture Partners.




